CDC is providing interim guidance to healthcare providers on clinical considerations for pregnant women with confirmed or probable Oropouche virus disease, and on evaluating and managing infants born to pregnant women with confirmed, probable or suspect Oropouche virus disease.
These interim guidance documents will be updated as we learn more about the potential risks of Oropouche virus disease during pregnancy.